The myopathy of peripheral arterial occlusive disease: part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction.
In recent years, an increasing number of studies have demonstrated that a myopathy is present, contributes, and, to a certain extent, determines the pathogenesis of peripheral arterial occlusive disease (PAD). These works provide evidence that a state of repetitive cycles of exercise-induced ischemia followed by reperfusion at rest operates in PAD patients and mediates a large number of structural and metabolic changes in the muscle, resulting in reduced strength and function. The key players in this process appear to be defective mitochondria that, through multilevel failure in their roles as energy, oxygen radical species, and apoptosis regulators, produce and sustain a progressive decline in muscle performance. In this 2-part review, we highlight the currently available evidence that characterizes the nature and mechanisms responsible for this myopathy. In part 1, the authors review the functional and histomorphological characteristics of the myopathy and focus on the biochemistry and bioenergetics of its mitochondriopathy. In part 2, they then review accumulating evidence that oxidative stress related to ischemia reperfusion is probably the major operating mechanism of PAD myopathy. Important new findings of a possible neuropathy and a shift in muscle fiber type are also reviewed. Learning more about these mechanisms will enhance our understanding of the degree to which they are preventable and treatable.
Pipinos
Iraklis I
II
Department of Surgery, University of Nebraska Medical Center, Omaha, NE 68198-3280, USA. ipipinos@unmc.edu
Judge
Andrew R
AR
Selsby
Joshua T
JT
Zhu
Zhen
Z
Swanson
Stanley A
SA
Nella
Aikaterini A
AA
Dodd
Stephen L
SL
D000818:Animals; D017209:Apoptosis; D001157:Arterial Occlusive Diseases / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D050260:Carbohydrate Metabolism; D002331:Carnitine / Q000031:analogs & derivatives / Q000378:metabolism; D004734:Energy Metabolism; D017079:Exercise Tolerance; D006439:Hemodynamics; D006801:Humans; D008854:Microscopy, Electron; D008931:Mitochondria, Muscle / Q000378:metabolism* / Q000648:ultrastructure; D053580:Muscle Strength; D018482:Muscle, Skeletal / Q000378:metabolism* / Q000503:physiopathology / Q000648:ultrastructure; D009135:Muscular Diseases / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D010085:Oxidative Phosphorylation; D018384:Oxidative Stress; D016491:Peripheral Vascular Diseases / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D011659:Pulmonary Gas Exchange
C116917:acylcarnitine; D002331:Carnitine